Characteristics | n | % |
---|---|---|
Female | 38 | 100 |
Age (median, years) | 62 years (range: 52–79) | |
Laterality | ||
Right | 18 | 47 |
Left | 20 | 53 |
Menopausal status | ||
Pre-menopausal | 0 | |
Post-menopausal | 37 | 97 |
Unknown | 1 | 3 |
Surgical margin | ||
Negative | 37 | 97 |
Positive | 1 | 3 |
Surgery, breast | ||
Lumpectomy | 38 | 100 |
Mastectomy | 0 | |
Surgery, Axilla | ||
None | 11 | 29 |
SLNBx | 27 | 71 |
ALND | 0 | |
Histology | ||
DCIS | 12 | 32 |
Invasive Ductal Carcinoma | 21 | 55 |
Invasive Lobular Carcinoma | 5 | 13 |
T stage | ||
Tis | 9 | 24 |
T1a | 5 | 13 |
T1b | 9 | 24 |
T1c | 12 | 32 |
T2 | 3 | 8 |
N stage | ||
N0 | 38 | 100 |
M stage | ||
M0 | 38 | 100 |
LVSI | ||
No | 11 | 29 |
Yes | 0 | |
Not reported | 27 | 71 |
Grade | ||
1 | 8 | 21 |
2 | 21 | 55 |
3 | 9 | 24 |
ER+ | 32 | 84 |
Unknown | 0 | |
PR+ | 20 | 53 |
Unknown | 8 | 21 |
HER2+ | 2 | 5 |
Unknown | 12 | 32 |
Multi-focal | 14 | 37 |
Hormonal therapy | 28 | 74 |
Chemotherapy | 5 | 13 |